United States Healthcare Equipment & Supplies

K2M Group Holdings Inc (KTWO)

Track

Ticker: KTWO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
425.25
Quantity 35,141 -1.7%
Value US$3,363,859
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
347.74
Quantity 65,100 -30.1%
Value US$1,262,775
MORATIS GEORGE Z Global Accounting Officer Officer
Transaction date
Planned sale
Price
188.79
Quantity 73,174 +43.5%
Value US$3,239,957
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
22.47
Quantity 867 -1.3%
Value US$19,482
MORATIS GEORGE Z Global Accounting Officer
Transaction date
Planned sale
Price
22.81
Quantity 455 -2.2%
Value US$10,378
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
23.30
Quantity 1,332 -0.7%
Value US$31,036
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
24.08
Quantity 1,090 -0.5%
Value US$26,247
Cole Gregory S Chief Financial Officer
Transaction date
Planned sale
Price
24.08
Quantity 2,350 -4.1%
Value US$56,588
MORATIS GEORGE Z Global Accounting Officer
Transaction date
Planned sale
Price
24.09
Quantity 770 -4.5%
Value US$18,549
Cole Gregory S Chief Financial Officer
Transaction date
Planned sale
Price
23.37
Quantity 39,357 -40.6%
Value US$919,631
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
24.33
Quantity 956 -1.6%
Value US$23,259
Cole Gregory S Chief Financial Officer
Transaction date
Planned sale
Price
22.73
Quantity 13,787 -19.1%
Value US$313,379
Cole Gregory S Chief Financial Officer
Transaction date
Planned sale
Price
22.83
Quantity 29,160 -33.4%
Value US$665,723
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Sale
Price
22.70
Quantity 50,000 -20.1%
Value US$1,135,000
MORATIS GEORGE Z Global Accounting Officer Officer
Transaction date
Sale
Price
21.77
Quantity 800 -6.0%
Value US$17,419
MORATIS GEORGE Z Global Accounting Officer Officer
Transaction date
Sale
Price
21.77
Quantity 200 -1.5%
Value US$4,354
MORATIS GEORGE Z Global Accounting Officer Officer
Transaction date
Sale
Price
21.61
Quantity 902 -6.3%
Value US$19,492
Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
Transaction date
Sale
Price
20.23
Quantity 3,926,068 -42.2%
Value US$79,424,356
WCAS Capital Partners IV, L.P. Large shareholder
Transaction date
Sale
Price
20.23
Quantity 57,488 -42.2%
Value US$1,162,982
WCAS MANAGEMENT CORP Large shareholder
Transaction date
Sale
Price
20.23
Quantity 3,214 -42.2%
Value US$65,019
Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
Transaction date
Sale
Price
20.23
Quantity 3,926,068 -42.2%
Value US$79,424,356
WCAS Capital Partners IV, L.P. Large shareholder
Transaction date
Sale
Price
20.23
Quantity 57,488 -42.2%
Value US$1,162,982
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
21.79
Quantity 561 -0.2%
Value US$12,225
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
21.61
Quantity 27,965 -10.1%
Value US$604,324
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
21.39
Quantity 27,969 -10.1%
Value US$598,257
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
21.58
Quantity 24,329 -8.9%
Value US$525,010
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
21.85
Quantity 20,000 -7.4%
Value US$436,996
WCAS Capital Partners IV, L.P. Large shareholder
Transaction date
Sale
Price
18.39
Quantity 64,674 -32.2%
Value US$1,189,355
WCAS Capital Partners IV, L.P. Large shareholder
Transaction date
Sale
Price
18.39
Quantity 64,674 -32.2%
Value US$1,189,355
WCAS MANAGEMENT CORP Large shareholder
Transaction date
Sale
Price
18.39
Quantity 3,616 -32.2%
Value US$66,498
Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
Transaction date
Sale
Price
18.39
Quantity 4,416,825 -32.2%
Value US$81,225,412
Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
Transaction date
Sale
Price
18.39
Quantity 4,416,825 -32.2%
Value US$81,225,412
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.70
Quantity 943 -2.3%
Value US$14,807
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.32
Quantity 6,465 -19.5%
Value US$73,184
Cole Gregory S Chief Financial Officer Officer
Transaction date
Sale
Price
11.45
Quantity 1,702 -11.9%
Value US$19,488
MORATIS GEORGE Z Global Accounting Officer Officer
Transaction date
Sale
Price
11.40
Quantity 900 -17.7%
Value US$10,260
FERRER CARLOS A Non-Executive Director
Transaction date
Purchase
Price
11.32
Quantity 20,000 +50.8%
Value US$226,400
FERRER CARLOS A Non-Executive Director
Transaction date
Purchase
Price
12.84
Quantity 38,942 +8850.5%
Value US$500,015
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
19.31
Quantity 20,245 -69.0%
Value US$390,931
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
20.07
Quantity 21,329 -70.1%
Value US$428,073
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
21.76
Quantity 1,200 -11.7%
Value US$26,112
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
20.99
Quantity 40,374 -79.7%
Value US$847,450
FERRER CARLOS A Non-Executive Director
Transaction date
Sale
Price
22.37
Quantity 3,042 -5.0%
Value US$68,050
FERRER CARLOS A Non-Executive Director
Transaction date
Sale
Price
22.37
Quantity 83,365 -5.0%
Value US$1,864,875
Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
Transaction date
Sale
Price
22.60
Quantity 467,293 -3.3%
Value US$10,560,822
WCAS MANAGEMENT CORP Large shareholder
Transaction date
Sale
Price
22.60
Quantity 383 -3.3%
Value US$8,656
WCAS Capital Partners IV, L.P. Large shareholder
Transaction date
Sale
Price
22.60
Quantity 6,842 -3.3%
Value US$154,629
WCAS Capital Partners IV, L.P. Large shareholder
Transaction date
Sale
Price
22.60
Quantity 6,842 -3.3%
Value US$154,629
Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
Transaction date
Sale
Price
22.60
Quantity 467,293 -3.3%
Value US$10,560,822
FERRER CARLOS A Non-Executive Director
Transaction date
Sale
Price
22.37
Quantity 20,279 -25.0%
Value US$453,641
FERRER CARLOS A Non-Executive Director
Transaction date
Sale
Price
22.37
Quantity 555,769 -25.0%
Value US$12,432,553
WCAS MANAGEMENT CORP Large shareholder
Transaction date
Sale
Price
22.60
Quantity 2,551 -18.0%
Value US$57,653
WCAS Capital Partners IV, L.P. Large shareholder
Transaction date
Sale
Price
22.60
Quantity 45,616 -18.0%
Value US$1,030,922
Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
Transaction date
Sale
Price
22.60
Quantity 3,115,287 -18.0%
Value US$70,405,486
WCAS Capital Partners IV, L.P. Large shareholder
Transaction date
Sale
Price
22.60
Quantity 45,616 -18.0%
Value US$1,030,922
Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
Transaction date
Sale
Price
22.60
Quantity 3,115,287 -18.0%
Value US$70,405,486
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
24.05
Quantity 8,848 -96.6%
Value US$212,794
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
24.01
Quantity 15,300 -98.0%
Value US$367,353
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
24.55
Quantity 14,841 -98.0%
Value US$364,347
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
24.27
Quantity 6,459 -2.7%
Value US$156,760
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
24.27
Quantity 8,034 -96.3%
Value US$194,985
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
24.89
Quantity 10,668 -4.3%
Value US$265,527
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
24.91
Quantity 10,711 -97.2%
Value US$266,811
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
25.36
Quantity 7,210 -3.0%
Value US$182,846
Cole Gregory S Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.36
Quantity 8,639 -96.6%
Value US$219,085
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
24.94
Quantity 18,165 -7.1%
Value US$453,035
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
24.80
Quantity 24,900 -11.6%
Value US$617,520
KOSTUIK JOHN PHILIP MD Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
24.28
Quantity 10,109 -4.5%
Value US$245,447
Cole Gregory S Chief Financial Officer Officer
Transaction date
Sale
Price
24.57
Quantity 13,350 -97.7%
Value US$328,010
BRODNAX BRETT Non-Executive Director
Transaction date
Sale
Price
19.73
Quantity 5,564 -17.1%
Value US$109,778
WCAS MANAGEMENT CORP Large shareholder
Transaction date
Sale
Price
18.75
Quantity 728 -4.9%
Value US$13,650
WCAS Capital Partners IV, L.P. Large shareholder
Transaction date
Sale
Price
18.75
Quantity 13,031 -4.9%
Value US$244,331
Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
Transaction date
Sale
Price
18.75
Quantity 889,990 -4.9%
Value US$16,687,312
Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
Transaction date
Sale
Price
18.75
Quantity 889,990 -4.9%
Value US$16,687,312
WCAS Capital Partners IV, L.P. Large shareholder
Transaction date
Sale
Price
18.75
Quantity 13,031 -4.9%
Value US$244,331
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-09-04 2018-08-30 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
35,141 -1.7%
425.25
US$3,363,859 		35,141 -1.7% 425.25 US$3,363,859
2018-08-17 2018-08-16 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
65,100 -30.1%
347.74
US$1,262,775 		65,100 -30.1% 347.74 US$1,262,775
2018-08-17 2018-08-16 PlS Planned sale MORATIS GEORGE Z

Global Accounting Officer

Officer
73,174 +43.5%
188.79
US$3,239,957 		73,174 +43.5% 188.79 US$3,239,957
2018-07-06 2018-07-03 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
867 -1.3%
22.47
US$19,482 		867 -1.3% 22.47 US$19,482
2018-06-08 2018-06-08 PlS Planned sale MORATIS GEORGE Z

Global Accounting Officer
455 -2.2%
22.81
US$10,378 		455 -2.2% 22.81 US$10,378
2017-08-24 2017-08-23 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
1,332 -0.7%
23.30
US$31,036 		1,332 -0.7% 23.30 US$31,036
2017-08-16 2017-08-15 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
1,090 -0.5%
24.08
US$26,247 		1,090 -0.5% 24.08 US$26,247
2017-08-16 2017-08-15 PlS Planned sale
Cole Gregory S

Chief Financial Officer
2,350 -4.1%
24.08
US$56,588 		2,350 -4.1% 24.08 US$56,588
2017-08-16 2017-08-15 PlS Planned sale MORATIS GEORGE Z

Global Accounting Officer
770 -4.5%
24.09
US$18,549 		770 -4.5% 24.09 US$18,549
2017-08-15 2017-08-11 PlS Planned sale Cole Gregory S

Chief Financial Officer
39,357 -40.6%
23.37
US$919,631 		39,357 -40.6% 23.37 US$919,631
2017-07-05 2017-07-01 PlS Planned sale
Cole Gregory S

Chief Financial Officer

Officer
956 -1.6%
24.33
US$23,259 		956 -1.6% 24.33 US$23,259
2017-06-16 2017-06-16 PlS Planned sale Cole Gregory S

Chief Financial Officer
13,787 -19.1%
22.73
US$313,379 		13,787 -19.1% 22.73 US$313,379
2017-06-16 2017-06-15 PlS Planned sale Cole Gregory S

Chief Financial Officer
29,160 -33.4%
22.83
US$665,723 		29,160 -33.4% 22.83 US$665,723
2017-05-30 2017-05-25 S Sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
50,000 -20.1%
22.70
US$1,135,000 		50,000 -20.1% 22.70 US$1,135,000
2017-05-15 2017-05-12 S Sale MORATIS GEORGE Z

Global Accounting Officer

Officer
800 -6.0%
21.77
US$17,419 		800 -6.0% 21.77 US$17,419
2017-05-15 2017-05-12 S Sale MORATIS GEORGE Z

Global Accounting Officer

Officer
200 -1.5%
21.77
US$4,354 		200 -1.5% 21.77 US$4,354
2017-05-10 2017-05-10 S Sale MORATIS GEORGE Z

Global Accounting Officer

Officer
902 -6.3%
21.61
US$19,492 		902 -6.3% 21.61 US$19,492
2017-02-14 2017-01-26 S Sale Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
3,926,068 -42.2%
20.23
US$79,424,356 		3,926,068 -42.2% 20.23 US$79,424,356
2017-02-14 2017-01-26 S Sale WCAS Capital Partners IV, L.P. Large shareholder
57,488 -42.2%
20.23
US$1,162,982 		57,488 -42.2% 20.23 US$1,162,982
2017-02-14 2017-01-26 S Sale WCAS MANAGEMENT CORP Large shareholder
3,214 -42.2%
20.23
US$65,019 		3,214 -42.2% 20.23 US$65,019
2017-02-14 2017-01-26 S Sale Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
3,926,068 -42.2%
20.23
US$79,424,356 		3,926,068 -42.2% 20.23 US$79,424,356
2017-02-14 2017-01-26 S Sale WCAS Capital Partners IV, L.P. Large shareholder
57,488 -42.2%
20.23
US$1,162,982 		57,488 -42.2% 20.23 US$1,162,982
2017-01-24 2017-01-23 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
561 -0.2%
21.79
US$12,225 		561 -0.2% 21.79 US$12,225
2017-01-24 2017-01-20 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
27,965 -10.1%
21.61
US$604,324 		27,965 -10.1% 21.61 US$604,324
2017-01-19 2017-01-19 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
27,969 -10.1%
21.39
US$598,257 		27,969 -10.1% 21.39 US$598,257
2017-01-19 2017-01-18 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
24,329 -8.9%
21.58
US$525,010 		24,329 -8.9% 21.58 US$525,010
2017-01-19 2017-01-17 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
20,000 -7.4%
21.85
US$436,996 		20,000 -7.4% 21.85 US$436,996
2016-11-18 2016-11-16 S Sale WCAS Capital Partners IV, L.P. Large shareholder
64,674 -32.2%
18.39
US$1,189,355 		64,674 -32.2% 18.39 US$1,189,355
2016-11-18 2016-11-16 S Sale WCAS Capital Partners IV, L.P. Large shareholder
64,674 -32.2%
18.39
US$1,189,355 		64,674 -32.2% 18.39 US$1,189,355
2016-11-18 2016-11-16 S Sale WCAS MANAGEMENT CORP Large shareholder
3,616 -32.2%
18.39
US$66,498 		3,616 -32.2% 18.39 US$66,498
2016-11-18 2016-11-16 S Sale Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
4,416,825 -32.2%
18.39
US$81,225,412 		4,416,825 -32.2% 18.39 US$81,225,412
2016-11-18 2016-11-16 S Sale Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
4,416,825 -32.2%
18.39
US$81,225,412 		4,416,825 -32.2% 18.39 US$81,225,412
2016-07-06 2016-07-01 PlS Planned sale
Cole Gregory S

Chief Financial Officer

Officer
943 -2.3%
15.70
US$14,807 		943 -2.3% 15.70 US$14,807
2016-05-24 2016-05-21 PlS Planned sale
Cole Gregory S

Chief Financial Officer

Officer
6,465 -19.5%
11.32
US$73,184 		6,465 -19.5% 11.32 US$73,184
2016-05-10 2016-05-07 S Sale
Cole Gregory S

Chief Financial Officer

Officer
1,702 -11.9%
11.45
US$19,488 		1,702 -11.9% 11.45 US$19,488
2016-05-10 2016-05-07 S Sale MORATIS GEORGE Z

Global Accounting Officer

Officer
900 -17.7%
11.40
US$10,260 		900 -17.7% 11.40 US$10,260
2016-05-05 2016-05-05 B Purchase FERRER CARLOS A Non-Executive Director
20,000 +50.8%
11.32
US$226,400 		20,000 +50.8% 11.32 US$226,400
2016-03-07 2016-03-07 B Purchase FERRER CARLOS A Non-Executive Director
38,942 +8850.5%
12.84
US$500,015 		38,942 +8850.5% 12.84 US$500,015
2015-11-13 2015-11-12 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
20,245 -69.0%
19.31
US$390,931 		20,245 -69.0% 19.31 US$390,931
2015-11-13 2015-11-11 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
21,329 -70.1%
20.07
US$428,073 		21,329 -70.1% 20.07 US$428,073
2015-08-11 2015-08-07 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
1,200 -11.7%
21.76
US$26,112 		1,200 -11.7% 21.76 US$26,112
2015-08-11 2015-08-07 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
40,374 -79.7%
20.99
US$847,450 		40,374 -79.7% 20.99 US$847,450
2015-07-21 2015-07-17 S Sale FERRER CARLOS A Non-Executive Director
3,042 -5.0%
22.37
US$68,050 		3,042 -5.0% 22.37 US$68,050
2015-07-21 2015-07-17 S Sale FERRER CARLOS A Non-Executive Director
83,365 -5.0%
22.37
US$1,864,875 		83,365 -5.0% 22.37 US$1,864,875
2015-07-17 2015-07-17 S Sale Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
467,293 -3.3%
22.60
US$10,560,822 		467,293 -3.3% 22.60 US$10,560,822
2015-07-17 2015-07-17 S Sale WCAS MANAGEMENT CORP Large shareholder
383 -3.3%
22.60
US$8,656 		383 -3.3% 22.60 US$8,656
2015-07-17 2015-07-17 S Sale WCAS Capital Partners IV, L.P. Large shareholder
6,842 -3.3%
22.60
US$154,629 		6,842 -3.3% 22.60 US$154,629
2015-07-17 2015-07-17 S Sale WCAS Capital Partners IV, L.P. Large shareholder
6,842 -3.3%
22.60
US$154,629 		6,842 -3.3% 22.60 US$154,629
2015-07-17 2015-07-17 S Sale Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
467,293 -3.3%
22.60
US$10,560,822 		467,293 -3.3% 22.60 US$10,560,822
2015-07-15 2015-07-13 S Sale FERRER CARLOS A Non-Executive Director
20,279 -25.0%
22.37
US$453,641 		20,279 -25.0% 22.37 US$453,641
2015-07-15 2015-07-13 S Sale FERRER CARLOS A Non-Executive Director
555,769 -25.0%
22.37
US$12,432,553 		555,769 -25.0% 22.37 US$12,432,553
2015-07-13 2015-07-13 S Sale WCAS MANAGEMENT CORP Large shareholder
2,551 -18.0%
22.60
US$57,653 		2,551 -18.0% 22.60 US$57,653
2015-07-13 2015-07-13 S Sale WCAS Capital Partners IV, L.P. Large shareholder
45,616 -18.0%
22.60
US$1,030,922 		45,616 -18.0% 22.60 US$1,030,922
2015-07-13 2015-07-13 S Sale Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
3,115,287 -18.0%
22.60
US$70,405,486 		3,115,287 -18.0% 22.60 US$70,405,486
2015-07-13 2015-07-13 S Sale WCAS Capital Partners IV, L.P. Large shareholder
45,616 -18.0%
22.60
US$1,030,922 		45,616 -18.0% 22.60 US$1,030,922
2015-07-13 2015-07-13 S Sale Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
3,115,287 -18.0%
22.60
US$70,405,486 		3,115,287 -18.0% 22.60 US$70,405,486
2015-06-29 2015-06-29 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
8,848 -96.6%
24.05
US$212,794 		8,848 -96.6% 24.05 US$212,794
2015-06-29 2015-06-26 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
15,300 -98.0%
24.01
US$367,353 		15,300 -98.0% 24.01 US$367,353
2015-06-29 2015-06-25 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
14,841 -98.0%
24.55
US$364,347 		14,841 -98.0% 24.55 US$364,347
2015-06-24 2015-06-24 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
6,459 -2.7%
24.27
US$156,760 		6,459 -2.7% 24.27 US$156,760
2015-06-24 2015-06-24 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
8,034 -96.3%
24.27
US$194,985 		8,034 -96.3% 24.27 US$194,985
2015-06-24 2015-06-23 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
10,668 -4.3%
24.89
US$265,527 		10,668 -4.3% 24.89 US$265,527
2015-06-24 2015-06-23 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
10,711 -97.2%
24.91
US$266,811 		10,711 -97.2% 24.91 US$266,811
2015-06-24 2015-06-22 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
7,210 -3.0%
25.36
US$182,846 		7,210 -3.0% 25.36 US$182,846
2015-06-24 2015-06-22 PlS Planned sale Cole Gregory S

Chief Financial Officer

Officer
8,639 -96.6%
25.36
US$219,085 		8,639 -96.6% 25.36 US$219,085
2015-06-23 2015-06-19 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
18,165 -7.1%
24.94
US$453,035 		18,165 -7.1% 24.94 US$453,035
2015-06-18 2015-06-18 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
24,900 -11.6%
24.80
US$617,520 		24,900 -11.6% 24.80 US$617,520
2015-06-18 2015-06-17 PlS Planned sale KOSTUIK JOHN PHILIP MD

Chief Medical Officer

Executive Director
10,109 -4.5%
24.28
US$245,447 		10,109 -4.5% 24.28 US$245,447
2015-06-05 2015-06-03 S Sale Cole Gregory S

Chief Financial Officer

Officer
13,350 -97.7%
24.57
US$328,010 		13,350 -97.7% 24.57 US$328,010
2015-02-13 2015-02-12 S Sale BRODNAX BRETT Non-Executive Director
5,564 -17.1%
19.73
US$109,778 		5,564 -17.1% 19.73 US$109,778
2015-02-10 2015-02-09 S Sale WCAS MANAGEMENT CORP Large shareholder
728 -4.9%
18.75
US$13,650 		728 -4.9% 18.75 US$13,650
2015-02-10 2015-02-09 S Sale WCAS Capital Partners IV, L.P. Large shareholder
13,031 -4.9%
18.75
US$244,331 		13,031 -4.9% 18.75 US$244,331
2015-02-10 2015-02-09 S Sale Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
889,990 -4.9%
18.75
US$16,687,312 		889,990 -4.9% 18.75 US$16,687,312
2015-02-10 2015-02-09 S Sale Welsh, Carson, Anderson & Stowe XI, L.P. Large shareholder
889,990 -4.9%
18.75
US$16,687,312 		889,990 -4.9% 18.75 US$16,687,312
2015-02-10 2015-02-09 S Sale WCAS Capital Partners IV, L.P. Large shareholder
13,031 -4.9%
18.75
US$244,331 		13,031 -4.9% 18.75 US$244,331
Explore more

More insider trading research around K2M Group Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America